Eculizumab (Soliris) and biosimilars (Bkemv, Epysqli) — coverage criteria
Customize your policy alerts
Sign up for Health Net Policy CP PHAR.97 alerts
Get alerted when Policy CP PHAR.97 changes without checking for updates manually.
Monitor payer policy activity
Policy governing medical necessity criteria, prior authorization, and continued use for eculizumab (Soliris) and biosimilars (Bkemv, Epijkstra) across covered lines of business; affects providers prescribing these agents for PNH, aHUS, gMG, NMOSD, and other indications for Health Net/Centene products.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.